A prospective,multicenter, randomized, parallel-group,open-label study of aripiprazole in the management of patients with schizophrenia
Not Applicable
- Conditions
- Schizophrenia
- Registration Number
- JPRN-UMIN000001650
- Lead Sponsor
- Department of Psychiatry, Graduate School of Medicine, Chiba University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
Pregnant or breastfeeding women. Not noticed as schizophrenia. With diabetes.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Preference of Medicine(POM)
- Secondary Outcome Measures
Name Time Method